Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

MiR-7 in neurological disorders: beyond metabolic dysregulation.

Created on 13 Oct 2026

Authors

Cristina Puigdueta, Virginia Pardo-Marqués, Marta Torrecilla-Parra, Mario Fernández-de Frutos, José L López-Aceituno, Carmen Zamora, Yaiza López-Manchedo, Rebeca Busto, Cristina M Ramírez

Published in

Frontiers in neuroscience. Volume 20. Pages 1884638. Epub Jul 30, 2026.

Abstract

Brain health depends on the fine coordination of metabolic and neuronal pathways, and disturbances in this balance are recognized as major drivers of neurodegenerative, neurological, and neuropsychiatric disorders. Increasing evidence indicates that microRNAs (miRNAs), as key post-transcriptional regulators of gene expression, play important roles in the molecular networks underlying neurological diseases by modulating pathways involved in energy metabolism, inflammation, oxidative stress, and neuronal survival. Among them, miR-7 has emerged as a particularly relevant regulator due to its high conservation, abundant expression in the central nervous system (CNS), and pleiotropic actions impacting both metabolic and neurodegenerative processes. This review focuses on current knowledge regarding miR-7 as a molecular node linking metabolic imbalance to neurological dysfunction, highlighting its regulatory targets and potential translational relevance in neurometabolic disorders.

PMID:
42597287
Bibliographic data and abstract were imported from PubMed on 13 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 4
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement